Clinical Trial Update: Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating letrozole in combination with lapatinib as neoadjuvant therapy for early breast cancer; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• Tykerb (lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 2 | Status: COMPLETED | Results posted: 2012-08-29